Company profile
NextImmune company profile
NextImmune focuses on the research and development of a new generation of immunosuppressive drugs for autoimmune diseases and Organ Transplantation - with objectives of high efficacy and good safety without adverse effects as known from conventional immunosuppressants.
Business identity
- Website
- https://www.nextimmune.com/
- Operating status
- Closed
- Company type
- For Profit
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Breíl, Grisons, Switzerland
- Country code
- CH
- Continent
- Europe